A phase I/II trial of reduced intensity allogeneic hematopoietic cell transplant for hematologic malignancies using cladribine, thiotepa and rabbit antithymocyte globulin

Jeremy T. Larsen, William J. Hogan, Ivana N. Micallef, Angela Dispenzieri, Morie A. Gertz, David J. Inwards, Han W. Tun, Vivek Roy, Susan M. Geyer, Jacob B. Allred, Wenting Wu, Stephen M. Ansell, Michelle A. Elliott, Ayalew Tefferi, Luis F. Porrata, Dennis A. Gastineau, Martha Q. Lacy, Mark R. Litzow

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'A phase I/II trial of reduced intensity allogeneic hematopoietic cell transplant for hematologic malignancies using cladribine, thiotepa and rabbit antithymocyte globulin'. Together they form a unique fingerprint.

Medicine & Life Sciences